TRISTEM LIMITED

Updated 322 days ago
Private Limited Company
  • Active - 12601923 (CH)
  • Age: 5 years
  • ID: 44066415/14
11 St John's Wood Park London, NW8 6QP United Kingdom
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 86220 - Specialists medical practice activities
The TriStem Group has been set up by Mr.Ghazi Dhoot and Dr. Ilham Saleh Abuljadayel to further research and develop its retrodifferentiation technology which is used to create stem cells from mature adult cells. The retrodifferentiation technology is based on the results of 12 years of research and currently TriStem is the only company that owns, and is in the process of commercialising, this technology. The main advantage of TriStem's new process over existing methods of harvesting stem cells is that it provides large quantities of stem cells which are by definition DNA matched and, therefore, bypasses the political and ethical issues concerned with therapeutic cloning.
Also known as: TriStem, TriStem Corporation, TriStem Group
Registration numbers: 12601923 (CH)
Primary location: London United Kingdom
  • 0
  • 0
Interest Score
2
HIT Score
0.43
CEO
Richard Williams
Chairman
Mr.Ghazi Dhoot
Chief Commercial Officer
Mr.Ghazi Dhoot
General
in..@tristemcorp.com

UK Company Data

Company number
12601923		 Account category
MICRO ENTITY		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2025-09-30		 Accounts last made up date
2023-12-31		 Returns next due date
2021-06-11		 Returns last made up date
N/A
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
tristemcorp.com
Actual
www.tristemcorp.com
IP
217.160.0.230
Status
OK
Category
Company
0 comments Add a comment